January Social Media Round-Up—2026 Strategic Priorities, Clinical Trials, and More
The new year is off to an exciting start here at Pfizer!
Already this year, we launched a new episode of “Rewrite the Recipe,” shined a light on the story of a lung cancer patient, The Pfizer Foundation has expanded its Action & Impact initiative, and that’s just the beginning.
During a busy trip to Davos, CEO Albert Bourla shared Pfizer’s strategic priorities for the year, sat down with The Wall Street Journal to discuss how the healthcare landscape is changing, and joined industry experts for the World Economic Forum Annual Meeting. Meanwhile, the rest of our leadership team announced exciting new clinical trials, shared positive results from ongoing studies, and shared their predictions for AI and digital technologies.
Check out the latest updates:
Executive Leadership
- CEO Albert Bourla shares Pfizer’s strategic priorities for 2026 at the J.P. Morgan Healthcare Conference
- Chief Scientific Officer Chris Boshoff announces the launch of new Phase 3 clinical trials at Pfizer
- Chief Digital and Technology Officer Lidia Fonseca shares predictions for AI and technology for 2026
- CEO Albert Bourla sits down with The Wall Street Journal to discuss the forces reshaping healthcare
- Chief Scientific Officer Chris Boshoff shares positive results from Pfizer’s pivotal study
- CEO Albert Bourla joins a panel with industry leaders at the World Economic Forum Annual Meeting
Pfizer on LinkedIn
- The Pfizer Foundation expands its Action & Impact initiative with $10 million in grants to help improve breast cancer care in sub-Saharan Africa
- Pfizer sits down with Debbie to discuss her experience with lung cancer
Pfizer on Instagram
Pfizer on X
Pfizer on TikTok
02.04.2026
02.02.2026
01.27.2026
01.13.2026